Histologically proven extranodal NK/T-cell lymphoma, nasal type according to the WHO classification (must be pathology-proven EBV DNA positive as well as cytoplasmic CD3 +, while CD56+ is not an essential diagnostic criteria. ). Newly diagnosed patients.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00292695

Locations

Taiwan

National Health Research Institutes, Lymphoma Disease Committee

Taipei, Taiwan

Sponsors and Collaborators

National Health Research Institutes, Taiwan

Mackay Memorial Hospital

National Cheng-Kung University Hospital

Taichung Veterans General Hospital

Taipei Veterans General Hospital, Taiwan

Kaohsiung Veterans General Hospital.

National Taiwan University Hospital

Tri-Service General Hospital

Chi Mei Medical Hospital

Kaohsiung Medical University

Changhua Christian Hospital

Buddhist Tzu Chi General Hospital

Investigators

Principal Investigator:

Ming-Chih Chang, M.D.

Lymphoma Disease Committee of Taiwan Cooperative Oncology Group

More Information

No publications provided by National Health Research Institutes, Taiwan